UChicago Medicine Faculty Physicians
Mary E. Rinella, MD
Mary E. Rinella, MD
UChicago Medicine Faculty Physicians
Professor of Medicine
Director, Metabolic and Fatty Liver Disease
Specialties
- Hepatology (Liver Diseases)
- Gastroenterology
- Transplant
Locations
- Chicago - River East
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Mary Rinella, MD, is a board-certified transplant hepatolgist with 20 years of experience treating patients with complex liver disease. Dr. Rinella is an expert in fatty liver disease (steatotic liver disease). Fatty liver disease is the most common cause of liver disease in the United States. In some people, fatty liver can progress to cirrhosis and liver failure, but if caught early, can be preventable. As part of our metabolic and fatty liver diseases program, Dr. Rinella provides comprehensive liver disease assessment and treatment, including nutritional intervention, the use of medications, endoscopy and clinical trials to deliver the most advanced treatment options.
While she has experience in treating all types of liver disease, in addition to fatty liver disease (steatotic liver disease), Dr. Rinella also has extensive interest and experience in the treatment of autoimmune and biliary liver diseases, such as autoimmune hepatitis, primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).
As part of her approach to care for liver disease patients, Dr. Rinella is passionate about using research to advance medicine. She has investigated a broad range of topics within steatotic liver disease, including the use of non-invasive measures to minimize the use of liver biopsy, steatotic liver disease before and after liver transplantation and the study of new therapies to treat steatotic liver disease, since there is still no FDA approved treatment. Dr. Rinella has published nearly 150 peer-review articles in prestigious journals, such as Nature Reviews Gastroenterology & Hepatology, Gastroenterology, Hepatology, Journal of the American Medical Association (JAMA), The Lancet and more.
Along with her clinical expertise and research accolades, Dr. Rinella is also dedicated to teaching residents and fellows, providing guidance and mentorship throughout their medical careers.
While she has experience in treating all types of liver disease, in addition to fatty liver disease (steatotic liver disease), Dr. Rinella also has extensive interest and experience in the treatment of autoimmune and biliary liver diseases, such as autoimmune hepatitis, primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).
As part of her approach to care for liver disease patients, Dr. Rinella is passionate about using research to advance medicine. She has investigated a broad range of topics within steatotic liver disease, including the use of non-invasive measures to minimize the use of liver biopsy, steatotic liver disease before and after liver transplantation and the study of new therapies to treat steatotic liver disease, since there is still no FDA approved treatment. Dr. Rinella has published nearly 150 peer-review articles in prestigious journals, such as Nature Reviews Gastroenterology & Hepatology, Gastroenterology, Hepatology, Journal of the American Medical Association (JAMA), The Lancet and more.
Along with her clinical expertise and research accolades, Dr. Rinella is also dedicated to teaching residents and fellows, providing guidance and mentorship throughout their medical careers.
Areas of Expertise
- Fatty Liver Disease (Steatotic Liver Disease)
- Liver Diseases
- Nonalcoholic Steatohepatitis (NASH)
- Primary Sclerosing Cholangitis PSC
- Primary Biliary Cholangitis PBC
- Liver Transplant
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Gastroenterology
- Transplant Hepatology
Practicing Since
- 2002
Languages Spoken
- English
- French
- Spanish
Medical Education
- University of Illinois College of Medicine
Residency
- University of Chicago Medicine
Fellowship
- Northwestern University Hospital
Memberships & Medical Societies
- American Association for the Study of Liver Diseases
- American College of Gastroenterology
- American Gastroenterological Association
- European Association for the Study of Liver Diseases
- International Liver Transplantation Society
- Mexican Hepatology Association
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
*Click Here to visit our insurance page and learn more.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.